Polysplenia syndrome as a risk factor for early progression of pulmonary hypertension

Akimichi Shibata, Hiroki Mori, Kazuki Kodo, Toshio Nakanishi, Hiroyuki Yamagishi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Recent progress in surgical and intensive care has improved the prognosis of congenital heart disease (CHD) associated with heterotaxy syndrome. Less is known, however, about pulmonary vascular complications in these patients. Methods and Results: We reviewed medical records of 236 patients who were diagnosed with polysplenia syndrome at 2 institutions for pediatric cardiology in Japan from 1978 to 2015. We selected and compared the clinical records of 16 patients with polysplenia who had incomplete atrioventricular septal defect (AVSD) as the polysplenia group, and 22 age-matched patients with incomplete AVSD without any syndromes including polysplenia as the control group. Although the severity of systemic to pulmonary shunt was not significantly different between the groups, mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance index (PVRI) were significantly higher in the polysplenia group than the control (mPAP, 37.3 vs. 19.1 mmHg, P=0.001; PVRI, 5.7 vs. 1.4 WU · m2, P=0.014) before surgical intervention. On regression analysis, polysplenia influenced the development of pulmonary hypertension (PH) regardless of age at evaluation or degree of systemic to pulmonary shunt in the patients with incomplete AVSD. Conclusions: Polysplenia syndrome is an independent risk factor for CHD-associated PH. Earlier intervention may be required to adjust the pulmonary blood flow in polysplenia syndrome with CHD to avoid the progression of PH.

Original languageEnglish
Pages (from-to)831-836
Number of pages6
JournalCirculation Journal
Volume83
Issue number4
DOIs
Publication statusPublished - 2019 Apr 1

Fingerprint

Heterotaxy Syndrome
Pulmonary Hypertension
Heart Diseases
Lung
Vascular Resistance
Pulmonary Artery
Pressure
Control Groups
Critical Care
Cardiology
Medical Records
Blood Vessels
Japan
Age Groups
Regression Analysis
Pediatrics
Atrioventricular Septal Defect

Keywords

  • Congenital heart disease
  • Heterotaxy
  • Incomplete atrioventricular septal defect
  • Isomerism

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Polysplenia syndrome as a risk factor for early progression of pulmonary hypertension. / Shibata, Akimichi; Mori, Hiroki; Kodo, Kazuki; Nakanishi, Toshio; Yamagishi, Hiroyuki.

In: Circulation Journal, Vol. 83, No. 4, 01.04.2019, p. 831-836.

Research output: Contribution to journalArticle

Shibata, Akimichi ; Mori, Hiroki ; Kodo, Kazuki ; Nakanishi, Toshio ; Yamagishi, Hiroyuki. / Polysplenia syndrome as a risk factor for early progression of pulmonary hypertension. In: Circulation Journal. 2019 ; Vol. 83, No. 4. pp. 831-836.
@article{eb3984b8792642ceb227006780183564,
title = "Polysplenia syndrome as a risk factor for early progression of pulmonary hypertension",
abstract = "Background: Recent progress in surgical and intensive care has improved the prognosis of congenital heart disease (CHD) associated with heterotaxy syndrome. Less is known, however, about pulmonary vascular complications in these patients. Methods and Results: We reviewed medical records of 236 patients who were diagnosed with polysplenia syndrome at 2 institutions for pediatric cardiology in Japan from 1978 to 2015. We selected and compared the clinical records of 16 patients with polysplenia who had incomplete atrioventricular septal defect (AVSD) as the polysplenia group, and 22 age-matched patients with incomplete AVSD without any syndromes including polysplenia as the control group. Although the severity of systemic to pulmonary shunt was not significantly different between the groups, mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance index (PVRI) were significantly higher in the polysplenia group than the control (mPAP, 37.3 vs. 19.1 mmHg, P=0.001; PVRI, 5.7 vs. 1.4 WU · m2, P=0.014) before surgical intervention. On regression analysis, polysplenia influenced the development of pulmonary hypertension (PH) regardless of age at evaluation or degree of systemic to pulmonary shunt in the patients with incomplete AVSD. Conclusions: Polysplenia syndrome is an independent risk factor for CHD-associated PH. Earlier intervention may be required to adjust the pulmonary blood flow in polysplenia syndrome with CHD to avoid the progression of PH.",
keywords = "Congenital heart disease, Heterotaxy, Incomplete atrioventricular septal defect, Isomerism",
author = "Akimichi Shibata and Hiroki Mori and Kazuki Kodo and Toshio Nakanishi and Hiroyuki Yamagishi",
year = "2019",
month = "4",
day = "1",
doi = "10.1253/circj.CJ-18-0933",
language = "English",
volume = "83",
pages = "831--836",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "4",

}

TY - JOUR

T1 - Polysplenia syndrome as a risk factor for early progression of pulmonary hypertension

AU - Shibata, Akimichi

AU - Mori, Hiroki

AU - Kodo, Kazuki

AU - Nakanishi, Toshio

AU - Yamagishi, Hiroyuki

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Background: Recent progress in surgical and intensive care has improved the prognosis of congenital heart disease (CHD) associated with heterotaxy syndrome. Less is known, however, about pulmonary vascular complications in these patients. Methods and Results: We reviewed medical records of 236 patients who were diagnosed with polysplenia syndrome at 2 institutions for pediatric cardiology in Japan from 1978 to 2015. We selected and compared the clinical records of 16 patients with polysplenia who had incomplete atrioventricular septal defect (AVSD) as the polysplenia group, and 22 age-matched patients with incomplete AVSD without any syndromes including polysplenia as the control group. Although the severity of systemic to pulmonary shunt was not significantly different between the groups, mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance index (PVRI) were significantly higher in the polysplenia group than the control (mPAP, 37.3 vs. 19.1 mmHg, P=0.001; PVRI, 5.7 vs. 1.4 WU · m2, P=0.014) before surgical intervention. On regression analysis, polysplenia influenced the development of pulmonary hypertension (PH) regardless of age at evaluation or degree of systemic to pulmonary shunt in the patients with incomplete AVSD. Conclusions: Polysplenia syndrome is an independent risk factor for CHD-associated PH. Earlier intervention may be required to adjust the pulmonary blood flow in polysplenia syndrome with CHD to avoid the progression of PH.

AB - Background: Recent progress in surgical and intensive care has improved the prognosis of congenital heart disease (CHD) associated with heterotaxy syndrome. Less is known, however, about pulmonary vascular complications in these patients. Methods and Results: We reviewed medical records of 236 patients who were diagnosed with polysplenia syndrome at 2 institutions for pediatric cardiology in Japan from 1978 to 2015. We selected and compared the clinical records of 16 patients with polysplenia who had incomplete atrioventricular septal defect (AVSD) as the polysplenia group, and 22 age-matched patients with incomplete AVSD without any syndromes including polysplenia as the control group. Although the severity of systemic to pulmonary shunt was not significantly different between the groups, mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance index (PVRI) were significantly higher in the polysplenia group than the control (mPAP, 37.3 vs. 19.1 mmHg, P=0.001; PVRI, 5.7 vs. 1.4 WU · m2, P=0.014) before surgical intervention. On regression analysis, polysplenia influenced the development of pulmonary hypertension (PH) regardless of age at evaluation or degree of systemic to pulmonary shunt in the patients with incomplete AVSD. Conclusions: Polysplenia syndrome is an independent risk factor for CHD-associated PH. Earlier intervention may be required to adjust the pulmonary blood flow in polysplenia syndrome with CHD to avoid the progression of PH.

KW - Congenital heart disease

KW - Heterotaxy

KW - Incomplete atrioventricular septal defect

KW - Isomerism

UR - http://www.scopus.com/inward/record.url?scp=85063712588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063712588&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-18-0933

DO - 10.1253/circj.CJ-18-0933

M3 - Article

C2 - 30842375

AN - SCOPUS:85063712588

VL - 83

SP - 831

EP - 836

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 4

ER -